![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1608867
¼ÒžÆÇ÷û ½ÃÀå : ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°Fetal Bovine Serum Market, By Application, By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, and Others), By Geography |
¼ÒžÆÇ÷û ½ÃÀåÀº 2024³â 18¾ï 6,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2031³â¿¡´Â 45¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 13.6%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÐ¼® ¹üÀ§ | ºÐ¼® »ó¼¼ | ||
---|---|---|---|
±âÁØ ¿¬µµ | 2023³â | ½ÃÀå ±Ô¸ð(2024³â) | 18¾ï 6,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2019-2023³â | ¿¹Ãø ±â°£ | 2024-2031³â |
¿¹Ãø ±â°£ÀÇ CAGR(2024-2031³â) | 13.60% | ¿¹Ãø ±Ý¾×(2031³â) | 45¾ï 4,000¸¸ ´Þ·¯ |
¼ÒžÆÇ÷ûÀº °úÇÐ ¿¬±¸ ¹× ´Ù¾çÇÑ ÀÇ·á °úÁ¤¿¡ »ç¿ëµÇ´Â Áß¿äÇÑ ¼¼Æ÷¹è¾ç ¹èÁö º¸ÃæÁ¦ÀÔ´Ï´Ù. žÆÇ÷û(FBS)Àº ÀӽŠ6°³¿ù°æ¿¡ µµÃàµÈ ÀÓ½ÅÇÑ ¼Ò¿¡¼ äÃëÇÑ ÅÂ¾Æ Ç÷¾×¿¡¼ ÃßÃâÇÑ ÅÂ¾Æ Ç÷¾× ¼¼Æ÷¿¡¼ ÃßÃâÇÑ ¼¼Æ÷¿¡¼ À¯·¡ÇÕ´Ï´Ù. ¼ÒžÆÇ÷û(FBS)¿¡´Â ¼¼Æ÷ÀÇ »ýÁ¸, ¼ºÀå, Áõ½Ä¿¡ ÇʼöÀûÀÎ ´Ù¾çÇÑ ¼ºÀåÀÎÀÚ, ´Ü¹éÁú, ºÎÂøÀÎÀÚ, ºñŸ¹ÎÀÌ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ¿¬±¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ Àü ¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀÇ ¼ºÀåÀº ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í »ý¸í°úÇÐ »ê¾÷ÀÇ ¿¬±¸ Ȱµ¿ Áõ°¡·Î ÀÎÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ »ý»êÀº ÃÖÀûÀÇ ¼¼Æ÷¹è¾ç Á¶°ÇÀ» À°¼ºÇϰí À¯ÁöÇϱâ À§ÇØ ¼Ò ÅÂ¾Æ ¼¼·³¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼ÒžÆÇ÷ûÀ» ÀÌ¿ëÇÑ ±¤¹üÀ§ÇÑ ¿¬±¸ Ȱµ¿À» ÇÊ¿ä·Î ÇÏ´Â ½Å¾à °³¹ß¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Ãà»ê¾÷ÀÇ °¡°Ý º¯µ¿°ú µ¿¹° º¹Áö °üÇà¿¡ ´ëÇÑ À±¸®Àû ¿ì·Á´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹«Ç÷û ¹× Á¦³ëÇÁ¸® ¼¼Æ÷¹è¾ç ¹èÁö·ÎÀÇ ÀüȯÀº ¼ÒžÆÇ÷û ½ÃÀå¿¡ µµÀüÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¸ÂÃãÇü ÀÇ·á, Àç»ý Ä¡·á, Áٱ⼼Æ÷ ¿¬±¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ º¸°í¼´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAG%)À» ºÐ¼®ÇÏ¿© Àü ¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÕ´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.
¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÀÛ¼ºµÇ¾ú½À´Ï´Ù.
ÁÖ¿ä ±â¾÷À¸·Î´Â Merck KGaA, Thermo Fisher Scientific Inc, HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc. Biologicals, Cytiva, Sartorius AG, SeraCare Life Sciences µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀ» ºÐ¼®ÇÒ ¶§ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
The fetal bovine serum market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to reach USD 4.54 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | 1.86 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 13.60% | 2031 Value Projection: | 4.54 Bn |
Fetal bovine serum is an important cell culture media supplement used in scientific research and various medical processes. It is derived from fetal blood cells obtained from fetal blood collected from slaughtered pregnant cattle around 6 months of gestation. Fetal bovine serum (FBS) contains various growth factors, proteins, attachment factors, and vitamins essential for cell survival, growth, and proliferation. The increasing demand for biopharmaceuticals and rising focus on cell-based research is driving the growth of the fetal bovine serum market globally.
The global fetal bovine serum market growth is driven by the rising demand for biopharmaceuticals and increasing research activities in life science industries. Biopharmaceutical production heavily relies on fetal bovine serum for growing and maintaining optimal cell culture conditions. Rising prevalence of chronic diseases is propelling the demand for new drug development which requires extensive research activities utilizing fetal bovine serum. However, price fluctuations in cattle farming and ethical concerns regarding animal welfare practices could hamper the market growth. Also, a shift towards serum-free and xeno-free cell culture mediums presents challenges to the fetal bovine serum market. Nonetheless, the growing focus on personalized medicine, regenerative therapies, and stem cell research are expected to present significant growth opportunities over the forecast period.
This report provides in-depth analysis of the global fetal bovine serum market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fetal bovine serum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc., Rocky Mountain Biologicals, Cytiva, Sartorius AG, and SeraCare Life Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global fetal bovine serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fetal bovine serum market